INS and metabolic dysfunction-associated steatotic liver disease: When NAFLD continuously progress to chronic inflammation, fibrosis, and cirrhosis, damaged hepatocytes result in the decline in hepatic glycogen synthesis, storage, decomposition, and the ability to regulate blood glucose homeostasis, manifested as impaired islet function and decreased insulin secretion (42).